These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2589268)

  • 21. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure.
    Mousson C; Justrabo E; Rifle G; Sgro C; Chalopin JM; Gérard C
    Nephron; 1993; 63(1):104-6. PubMed ID: 8446234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piridoxilate-associated calcium oxalate urinary calculi: a new metabolic drug-induced nephrolithiasis.
    Daudon M; Reveillaud RJ; Jungers P
    Lancet; 1985 Jun; 1(8441):1338. PubMed ID: 2860529
    [No Abstract]   [Full Text] [Related]  

  • 24. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate.
    McCormick K; Viscardi RM; Robinson B; Heininger J
    Am J Med Genet; 1985 Oct; 22(2):291-9. PubMed ID: 4050860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis.
    Daudon M; Reveillaud RJ; Normand M; Petit C; Jungers P
    J Urol; 1987 Aug; 138(2):258-61. PubMed ID: 3599232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of sodium benzoate to alleviate plasma and liver ammonia in rats.
    Palekar AG; Canas JA; Kalbag SS; Kim SJ; Castro-Magana M; Angulo MA
    Biochem Med Metab Biol; 1989 Feb; 41(1):64-9. PubMed ID: 2713151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of severe carbamyl phosphate synthetase I deficiency.
    Van de Bor M; Mooy P; van Zoeren D; Berger R; van Gelderen HH; Teijema HL
    Arch Dis Child; 1984 Dec; 59(12):1183-5. PubMed ID: 6524951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of hyperammonemia by sodium benzoate in animals. A note of caution.
    O'Connor JE; Ribelles M; Grisolia S
    Eur J Pediatr; 1982 Mar; 138(2):186-7. PubMed ID: 7094940
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.
    Batshaw ML; Brusilow S; Waber L; Blom W; Brubakk AM; Burton BK; Cann HM; Kerr D; Mamunes P; Matalon R; Myerberg D; Schafer IA
    N Engl J Med; 1982 Jun; 306(23):1387-92. PubMed ID: 7078580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of sodium benzoate in newborn infants with hyperammonemia.
    Green TP; Marchessault RP; Freese DK
    J Pediatr; 1983 May; 102(5):785-90. PubMed ID: 6842341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites.
    Qureshi IA; Letarte J; Ouellet R
    Adv Exp Med Biol; 1982; 153():173-83. PubMed ID: 7164896
    [No Abstract]   [Full Text] [Related]  

  • 38. Potentiation of benzoate toxicity by glyoxylate. Inhibition of pyruvate carboxylase and the urea cycle.
    Cyr DM; Tremblay GC
    Biochem Pharmacol; 1989 Sep; 38(17):2919-23. PubMed ID: 2775312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.